Clinical Trials Sponsored by Jiangsu Institute of Nuclear Medicine

Total 2990 results

Wuxi People's Hospital
Jiangsu Institute of Nuclear Medicine

Unknown

Serological Screening of Gastric Cancer in Wuxi Region

Stomach Neoplasms
Clinical Centre of Serbia
Center of nuclear medicine; Institute for histology

Unknown

Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients (PATA-STEMI)

Myocardial Infarction

Serbia
Institute of Nuclear Energy Research, Taiwan

Terminated

to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage

Tumors

Taiwan
Institute of Nuclear Energy Research, Taiwan

Completed

to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

Safety Issues

Taiwan
Institute of Nuclear Energy Research, Taiwan

Completed

to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

Hepatic Carcinoma

Taiwan
Jiangsu Cancer Institute & Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma
Medical University of South Carolina
National Institutes of Health (NIH); Society of Nuclear Medicine

Withdrawn

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

Depression | Obesity | Anxiety | Panic Disorder | Gastric Emptying

United States
Asian Institute of Gastroenterology, India
KK Nuclear Scan

Completed

Gastric Emptying After Infracolic or Supracolic Gastrojejunostomy Following Pancreaticoduodenectomy

Postprocedural Gastric Stasis

India
Aarhus University Hospital Skejby
Department of Nuclear Medicine, Aarhus University Hospital

Active, not recruiting

The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory (FLOW3)

Coronary Artery Disease

Denmark
Jonsson Comprehensive Cancer Center
Society of Nuclear Medecine and Molecular Imaging

Recruiting

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Breast Carcinoma | Gastric Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Ovarian Carcinoma | Colon Carcinoma | Esophageal Carcinoma | Kidney Carcinoma | Pancreatic Carcinoma | Uterine Corpus Cancer | Solid Neoplasm

United States
Jiangsu Province Hospital of Traditional Chinese...

Unknown

Electric Acupuncture for ICU-acquired Weakness in Mechanical Ventilation Patients (EA-ICUAW)

Sepsis | Respiratory Failure | Multiple Organ Dysfunction Syndrome

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003)

Lung Carcinoma

China
Jiangsu Province Hospital of Traditional Chinese...

Unknown

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Peripheral Neuropathy

China
Heidelberg University
Novartis Pharmaceuticals; Siemens Healthcare Diagnostics Inc; Institute of Clinical...

Completed

Unifying Advanced Treatment With Advanced Imaging (GISTm3)

Gastrointestinal Stromal Tumor (GIST)

Germany
Tri-Service General Hospital
Institute of Nuclear Energy Research, Taiwan

Completed

The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD (STAPMDDTDM)

Major Depressive Disorder
Jiangsu Famous Medical Technology Co., Ltd.
Jiangsu Province Hospital of Traditional Chinese Medicine

Recruiting

Xian-Lian-Jie-Du Optimization Decoction as an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer

Colon Cancer

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.; BGI-Shenzhen

Completed

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma | Immunotherapy

China
Henan University of Traditional Chinese Medicine
Jiangsu Province Hospital of Traditional Chinese Medicine

Unknown

Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD

Chronic Obstructive Pulmonary Disease

China
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Completed

A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Ovarian Cancer | Triple Negative Breast Cancer

China
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Non-Small-Cell Lung Cancer

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Recruiting

A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms

Relapsed or Refractory Mature Lymphoid Neoplasms

China
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients

Melanoma

China
Peking University Cancer Hospital & Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

China
Jiangxi University of Traditional Chinese Medicine

Recruiting

Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

China
Jiangxi University of Traditional Chinese Medicine

Active, not recruiting

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

Primary Hypertension

China
Jiangxi University of Traditional Chinese Medicine

Recruiting

Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

China
Jiangxi University of Traditional Chinese Medicine

Not yet recruiting

Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia

Dyslipidemias

China
Jiangxi University of Traditional Chinese Medicine

Completed

Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

China
Shanghai Jiao Tong University School of Medicine
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Breast Cancer Invasive

China
Shanghai Jiao Tong University School of Medicine
Jiangsu HengRui Medicine Co., Ltd.

Terminated

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Breast Cancer

China
Yun Chen

Recruiting

QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology

Menopause

China
Yun Chen

Completed

Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons (QXZSKNDy)

Menopause

China
Yun Chen

Recruiting

Real-world Evaluation of Qingxin Zishen Decoction on Ovarian Reserve Function Clinical Efficacy in Patients With Decreased

Decreased Ovarian Reserve

China
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Completed

Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-small-cell Lung Cancer

China
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-Small-Cell Lung

China
National Council of Scientific and Technical Research...
Center for Nuclear and Molecular Medicine Entre Ríos

Recruiting

Tools for the Differential Diagnosis of Fibromyalgia Based on Cognitive Tasks

Fibromyalgia

Argentina
Hospital of Stomatology, Wuhan University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma (NEOPCOSCC)

Oral Squamous Cell Carcinoma

China
Hospital of Stomatology, Wuhan University
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma (NEOPBOSCC)

Oral Squamous Cell Carcinoma

China
The People's Hospital of Leshan
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Apatinib Treatment in for Advanced Ovarian Cancer

Ovarian Cancer | Chemotherapeutic Toxicity

China
Qilu Hospital of Shandong University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing University of Chinese Medicine

Unknown

A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Hand, Foot and Mouth Disease

China
Shanghai University of Traditional Chinese Medicine
Jiangsu Province Hospital of Traditional Chinese Medicine; RenJi Hospital

Completed

The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer (CHANGE)

Gastric Cancer Stage IIIB | Gastric Cancer Stage IIIC

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Borderline Resectable Pancreatic Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis

Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer (APPROVE)

Platinum-resistant Recurrent Ovarian Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR

Lung Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Terminated

Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer

Breast Cancer

China

Clinical Trials Sponsored by Jiangsu Institute of Nuclear Medicine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations